Testing kits on Delta Variant

NASDAQ:QDEL   Quidel Corporation
Quidel: a manufacturer of diagnostic products, frequently rises or sinks in response to developments in the coronavirus pandemic, as a big part of their revenue comes from its COVID-19 testing kits.

As the Delta Variant is worrying countries around the globe, QDEL will be interesting to watch.

Technical Analysis
As you can see in the weekly chart, the blue horizontal line which is approximately $150 was tested multiple times, is now also coinciding with the 50ema, which has worked well as support.

A potential target could be in place, as there is still a downtrend from the Pfizer Vaccine initial news of 95% efficacy.